Cassava Sciences plunges 40% after simufilam researcher indicted on fraud charges [Seeking Alpha]
Cassava Sciences, Inc. (SAVA)
Last cassava sciences, inc. earnings: 8/12 08:30 am
Check Earnings Report
Company Research
Source: Seeking Alpha
The charges against CUNY School of Medicine Professor Hoau-Yan Wang for falsifying data are regarding Cassava's Alzheimer's drug, simufilam, that Wang used to apply for NIH grants. A total of $16M was awarded to Cassava based on Wang's data, according to the indictment. He is charged with one count of major fraud, two counts of wire fraud, and a single count of false statements. "From approximately May 2015 through approximately April 2023, Wang allegedly engaged in a scheme to fabricate and falsify scientific data in grant applications made to the NIH on behalf of himself and the biopharmaceutical company," a Justice Department news release reads. The $16M in grants was dispersed between 2017 and 2021, "part of which funded Wang's laboratory work and salary," according to the DoJ. In March, Science magazine obtained a copy of an FDA inspection report of Wang's CUNY lab conducted in September 2022 finding that Wang used improper statistical tests and noting that university of
Show less
Read more
Impact Snapshot
Event Time:
SAVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SAVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SAVA alerts
High impacting Cassava Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
SAVA
News
- Embattled Alzheimer’s Researcher Is Charged With Fraud [The New York Times]The New York Times
- Cassava Sciences Issues Statement on Former Science Advisor [Yahoo! Finance]Yahoo! Finance
- Cassava Sciences Issues Statement on Former Science AdvisorGlobeNewswire
- Lifshitz Law PLLC Announces Investigations of Cassava Sciences, Inc. (NASDAQ: SAVA), iRhythm Technologies, Inc. (NASDAQ: IRTC), Xponential Fitness, Inc. (NYSE: XPOF), and Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX)Accesswire
- Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Golden Cross [Yahoo! Finance]Yahoo! Finance
SAVA
Earnings
- 5/10/24 - Beat
SAVA
Sec Filings
- 5/22/24 - Form 8-K
- 5/22/24 - Form 4
- 5/22/24 - Form 4
- SAVA's page on the SEC website